S. Chris Pappas

3.6k total citations · 1 hit paper
66 papers, 2.2k citations indexed

About

S. Chris Pappas is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S. Chris Pappas has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 34 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in S. Chris Pappas's work include Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (25 papers) and Hepatitis C virus research (15 papers). S. Chris Pappas is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (25 papers) and Hepatitis C virus research (15 papers). S. Chris Pappas collaborates with scholars based in United States, Canada and Ireland. S. Chris Pappas's co-authors include E. Anthony Jones, Daniel F. Schafer, Khurram Jamil, Gerald Y. Minuk, Florence Wong, Arun J. Sanyal, K. Rajender Reddy, Jay H. Hoofnagle, Michael K. Porayko and Ruth Jacobs and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

S. Chris Pappas

63 papers receiving 2.1k citations

Hit Papers

Terlipressin plus Albumin for the Treatment of Type 1 Hep... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
    2021 246 citations Florence Wong, S. Chris Pappas et al. profile →

Peers

S. Chris Pappas
Juan A. del Olmo Spain
Phillip Harrison United Kingdom
Emilio Fábrega Spain
Peter Ferenci Austria
Conrado Fernández‐Rodríguez Spain
Jeffery L. Steers United States
W. Lauchart Germany
David Bauer Austria
S. Friman Sweden
Nick Murphy United Kingdom
Juan A. del Olmo Spain
S. Chris Pappas
Citations per year, relative to S. Chris Pappas S. Chris Pappas (= 1×) peers Juan A. del Olmo

Countries citing papers authored by S. Chris Pappas

Since Specialization
Citations

This map shows the geographic impact of S. Chris Pappas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chris Pappas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chris Pappas more than expected).

Fields of papers citing papers by S. Chris Pappas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chris Pappas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chris Pappas. The network helps show where S. Chris Pappas may publish in the future.

Co-authorship network of co-authors of S. Chris Pappas

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chris Pappas. A scholar is included among the top collaborators of S. Chris Pappas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chris Pappas. S. Chris Pappas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weinberg, Ethan M., Florence Wong, Hugo E. Vargas, et al.. (2023). Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transplantation. 30(4). 347–355. 3 indexed citations
3.
Pappas, S. Chris. (2021). Hepatitis B and Health Care Workers. Clinics in Liver Disease. 25(4). 859–874. 7 indexed citations
4.
Jamil, Khurram, S. Chris Pappas, Florence Wong, & Arun J. Sanyal. (2019). <p>Verified Hepatorenal Syndrome Reversal As A Robust Multi-Component Primary End Point: The CONFIRM Study Trial Design</p>. Volume 11. 67–73. 2 indexed citations
5.
Balakrishnan, Maya & S. Chris Pappas. (2018). Alcohol and the Law. Clinics in Liver Disease. 23(1). 25–38. 3 indexed citations
6.
Jamil, Khurram, S. Chris Pappas, & Krishna Devarakonda. (2017). In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V<sub>1</sub> and V<sub>2</sub>. Journal of Experimental Pharmacology. Volume 10. 1–7. 38 indexed citations
7.
Lin, Michael M., S. Chris Pappas, Joseph H. Sellin, & Hashem B. El‐Serag. (2015). Curbside Consultations: The Good, the Bad, and the Ugly. Clinical Gastroenterology and Hepatology. 14(1). 2–4. 7 indexed citations
8.
Diago, M., Mitchell L. Shiffman, Jean–Pierre Bronowicki, et al.. (2010). Identifying Hepatitis C Virus Genotype 2/3 Patients Who Can Receive A 16-Week Abbreviated Course of Peginterferon Alfa-2A (40Kd) Plus Ribavirin. Hepatology. 51(6). 1897–1903. 45 indexed citations
9.
Stefanidis, Alexandros, et al.. (2009). Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults. European Journal of Echocardiography. 10(5). 647–653. 14 indexed citations
10.
11.
Pappas, S. Chris, Lisa M. Nyberg, Susan Greenbloom, et al.. (2006). 734 Peginterferon alpha-2a (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks in patients with HCV genotype 2 OR 3. Final results of the accelerate trial. Journal of Hepatology. 44. S271–S271. 23 indexed citations
12.
Petrikkos, G., Konstantinos Makrilakis, & S. Chris Pappas. (2006). Affirm VP III in the detection and identification of Candida species in vaginitis. International Journal of Gynecology & Obstetrics. 96(1). 39–40. 10 indexed citations
13.
Lee, Samuel S., E. Jenny Heathcote, K. Rajender Reddy, et al.. (2002). Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). Journal of Hepatology. 37(4). 500–506. 112 indexed citations
14.
Krowka, Michael J., Michael K. Porayko, David J. Plevak, et al.. (1997). Hepatopulmonary Syndrome With Progressive Hypoxemia as an Indication for Liver Transplantation: Case Reports and Literature Review. Mayo Clinic Proceedings. 72(1). 44–53. 149 indexed citations
15.
Heathcote, E. Jenny, Karen Cauch‐Dudek, Keith O’Rourke, et al.. (1996). Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?. Hepatology. 23(5). 1148–1153. 75 indexed citations
16.
Pappas, S. Chris, et al.. (1996). Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction. Metabolism. 45(5). 652–657. 27 indexed citations
17.
Martin, Paul & S. Chris Pappas. (1990). Fulminant Hepatic Failure. Digestive Diseases. 8(3). 138–151. 12 indexed citations
18.
Pappas, S. Chris. (1988). Fulminant Hepatic Failure and the Need for Artificial Liver Support. Mayo Clinic Proceedings. 63(2). 198–200. 20 indexed citations
19.
Klein, A., S. Chris Pappas, Phillip Gordon, et al.. (1988). The effect of nonviral liver damage on the T-lymphocyte helper/suppressor ratio. Clinical Immunology and Immunopathology. 46(2). 214–220. 2 indexed citations
20.
Pappas, S. Chris, Péter Ferenci, Daniel F. Schafer, & E. Anthony Jones. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.. PubMed. 86(3). 546–51. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan A. del Olmo Breakdown of academic impact, for papers by Phillip Harrison Breakdown of academic impact, for papers by Emilio Fábrega Breakdown of academic impact, for papers by Peter Ferenci Breakdown of academic impact, for papers by Conrado Fernández‐Rodríguez Breakdown of academic impact, for papers by Jeffery L. Steers Breakdown of academic impact, for papers by W. Lauchart Breakdown of academic impact, for papers by David Bauer Breakdown of academic impact, for papers by S. Friman Breakdown of academic impact, for papers by Nick Murphy
Rankless by CCL
2026